Clinical trial gives young pitcher a path back to baseball
When Chance Shipley was finishing high school in Southern California, baseball defined his future. A pitcher with a college scholarship, he was training for the transition to collegiate athletics when he became seriously ill during winter break in December 2019. He was vomiting, exhausted and noticed ...
Featured News
Mpox study reveals hidden infections may fuel spread
A Kaiser Permanente study of nearly 8,000 men shows that in mid- to late 2024, mpox was far more common among men who have sex with men than previously thought. Individuals without symptoms accounted ...
DoxyPEP protects against some STIs, but effectiveness against gonorrhea diminishes
Taking doxycycline after sex helped prevent chlamydia and syphilis, but its ability to prevent gonorrhea faded over time as drug‑resistant strains became more common, according to new research. The ...
Education-focused diabetes care linked to better blood sugar control
A large study conducted within Kaiser Permanente Southern California found that people with type 2 diabetes who primarily received diabetes self-management education and support were more likely to ...
Five questions for Dr. Sujatha Murali
October 1, 2025Sujatha Murali, MD, MS is a hematologist and medical oncologist in San Diego and currently serves as the Southern California Breast Cancer Lead and Principal Investigator for breast cancer clinical trials within Kaiser Permanente Southern California’s Cancer Clinical Trials Access Program. She joined Kaiser Permanente in 2016 after working at the Winship Cancer Institute of ...Read more...Opioid tapering and risk of overdose
September 8, 2025After the Centers for Disease Control and Prevention issued opioid prescribing guidelines in 2016, the national opioid dispensing rates steadily declined. However, while reducing opioid prescriptions is critically important, abruptly stopping opioids for pain has been shown to possibly raise the risk of overdose for patients. Against this backdrop, Kaiser Permanente was among the first health ...Read more...Five questions for Dr. Talar Habeshian
September 8, 2025Talar Habeshian, PhD, MPH, was appointed as a postdoctoral research fellow in the Division of Epidemiologic Research at the Department of Research & Evaluation in August. She will focus on cancer research initiatives. Prior to her postdoctoral appointment, Dr. Habeshian worked as a research associate in the Division of Health Services Research & Implementation Science for ...Read more...COVID-19 vaccination not linked to tinnitus
August 12, 2025New Kaiser Permanente research shows that the COVID-19 vaccine does not increase the risk of developing tinnitus, which is a ringing in the ears. “Early on in the COVID-19 pandemic, some people complained about hearing some sound after being vaccinated, but it wasn’t actually an external sound, it was tinnitus, which is the perception of sound ...Read more...Fewer breast cancer patients received imaging follow-up after COVID-19 hit
August 12, 2025A new Kaiser Permanente study showed that fewer breast cancer survivors received recommended annual breast cancer imaging in the time after the COVID-19 pandemic period compared to before the pandemic. The study was published in JAMA Oncology in July 2025. Little has been known previously about the impact of the COVID-19 pandemic on post-treatment surveillance for ...Read more...Finding factors that could help patients achieve remission from Type 2 diabetes
August 12, 2025A diagnosis of Type 2 diabetes typically means a future of blood sugar monitoring and glucose-lowering medications. But interest is growing in identifying which people with diabetes might be able to stop taking their medications and control their disease with diet and exercise alone. A new Kaiser Permanente study, published in Diabetes Care, sheds light ...Read more...Five questions for Dr. Taynara Formagini
July 24, 2025A behavioral and public health scientist, Taynara Formagini, PhD, MSc, is a postdoctoral research fellow in the Department of Research & Evaluation. Her work focuses on preventing cardiovascular and chronic diseases among racial and ethnic minorities and socioeconomically disadvantaged populations through a combination of intervention research and epidemiology. What inspired you to pursue research? I’m a first-generation ...Read more...Comorbidities could increase risk of other cancers for breast cancer survivors
July 24, 2025Kaiser Permanente research found that breast cancer survivors have a higher risk of developing other cancers if they have other preexisting health conditions, such as high blood pressure and diabetes. “Preexisting health conditions are common in people diagnosed with cancer and what we’ve learned with this study is that comorbidities — experiencing multiple illnesses or disorders ...Read more...Five questions for Dr. Maheen Humayun
July 24, 2025Maheen Humayun, PhD, MPH, is an infectious disease epidemiologist and postdoctoral research fellow in the Department of Research & Evaluation. Prior to joining Kaiser Permanente, Dr. Humayun worked as an HIV Cluster Detection and Response Fellow at the Centers for Disease Control and Prevention. In that role, she analyzed national HIV surveillance data to detect rapid ...Read more...Opioid use associated with increased risk of mortality for breast cancer survivors
July 24, 2025About 16% of breast cancer survivors continued to use opioid pain medications after their cancer treatment was complete, a new Kaiser Permanente study showed. The study also found that risk of death was 84% higher among these survivors who continued to use opioids. The study was published in June 2025 in JNCI Cancer Spectrum. “The most important ...Read more...